Benchling, which supplies cloud-based software program to handle biotech R&D, raises $200M led by Sequoia Capital World Equities at $4B valuation, 5x its worth in Might (Amy Feldman/Forbes)




Amy Feldman / Forbes:

Benchling, which supplies cloud-based software program to handle biotech R&D, raises $200M led by Sequoia Capital World Equities at $4B valuation, 5x its worth in Might  —  Sajith Wickramasekara was simply 24 when he made the minimize for the Forbes 30 Underneath 30 record for his biotech R&D startup, Benchling.





Supply hyperlink

Leave a Reply

Your email address will not be published. Required fields are marked *